Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports

Autor:	Renato Cutrera, Andrea Wolfler, Simonetta Picone, Giovanni A. Rossi, Giuliana Gualberti, Rocco Merolla, Antonio Del Vecchio, Alberto Villani, Fabio Midulla, Andrea Dotta
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Bronchiolitis Respiratory syncytial virus Prophylaxis Palivizumab Preterm infants pediatric intensive care units Pediatrics RJ1-570
Zdroj:	Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-9 (2019)
Druh dokumentu:	article
ISSN:	1824-7288
DOI:	10.1186/s13052-019-0736-5
Popis:	Abstract Background The only pharmacologic prophylaxis against respiratory syncytial virus (RSV) infection in preterm infants is the humanized monoclonal antibody palivizumab. After the 2014 modification of the American Academy of Pediatrics (AAP) recommendations, the Italian Medicines Agency (AIFA) limited the financial coverage for palivizumab prescriptions to otherwise healthy preterm infants with
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/4a644600b6d04cd181962f9dd1adec75 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.